Buy Drugs Online:
Drugs Information:
Drugs List

1. Name Of The Medicinal Product

Sectral 400mg Tablets

2. Qualitative And Quantitative Composition

Each tablet contains 443.40mg of the active substance Acebutolol hydrochloride (equivalent to 400mg of base).

Also contains 21.20mg of lactose monohydrate.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Tablet

White to off-white, circular, biconvex, film-coated tablets with bevel edges, one face impressed 'SECTRAL 400 or ACB 400. Plain reverse.

4. Clinical Particulars

4.1 Therapeutic Indications

The management of hypertension, angina pectoris and the control of tachyarrhythmias.

4.2 Posology And Method Of Administration

Hypertension: Initial dosage of 400mg orally once daily at breakfast or 200mg orally twice daily. If response is not adequate within two weeks, dosage may be increased up to 400mg orally twice daily; in some patients 1200mg orally daily, given as 800mg at breakfast and 400mg in the evening may be required. A further reduction in blood pressure may be obtained by the concurrent administration of a thiazide diuretic or other anti-hypertensive agent (except Rauwolfia and its alkaloids).

Angina pectoris: Initial dosage of 400mg orally once daily at breakfast or 200mg twice daily. In severe forms up to 300mg three times daily may be required. Up to 1200mg daily has been used.

Cardiac Arrhythmias: When given orally, an initial dose of 200mg is recommended. The daily dose requirement for long term anti arrhythmic activity should lie between 400 and 1200mg daily. The dose can be gauged by response, and better control may be achieved by divided doses rather than single doses. It may take up to three hours for maxima

1. Name Of The Medicinal Product

Aspirin 75mg Gastro-resistant Tablets

Boots Aspirin 75mg Gastro-resistant Tablets

2. Qualitative And Quantitative Composition

Each tablet contains aspirin 75mg

For a full list of excipients see section 6.1

3. Pharmaceutical Form

Gastro-resistant tablet

White circular tablet, plain on both sides.

4. Clinical Particulars

4.1 Therapeutic Indications

For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery.

4.2 Posology And Method Of Administration

Aspirin 75 mg is for oral administration to adults only.

Take the tablet with water, do not cut, chew or crush the tablet. Swallow whole.

The advice of a doctor should be sought before commencing therapy for the first time.

The usual dosage, for long term use, is 75mg-150mg once daily. In some circumstances a higher dose may be appropriate, especially in the short term, and up to 300mg a day may be used on the advice of a doctor.

In Elderly: The risk-benefit ratio of the antithrombotic action of aspirin has not been fully established.

Children:

Do not give to children aged under 16 years, unless specifically indicated (e.g. for Kawasaki's disease). See Section 4.4

4.3 Contraindications

• Hypersensitivity to aspirin or any other NSAIDs, or any of the excipients (see section 6.1)

• Active peptic ulceration or history of peptic ulceration

• Haemophilia, other coagulopathies including hypoprothrombinaemia or concurrent anticoagulant therapy

• Gout

• Do not give t

1. Name Of The Medicinal Product

FemSeven Sequi, 50 micrograms/10 micrograms/24 hours, transdermal patch

2. Qualitative And Quantitative Composition

Phase 1:

Each patch contains 1.5 mg of estradiol hemihydrate in a patch size of 15 cm2, releasing 50 micrograms of estradiol per 24 hours.

Phase 2:

Each patch contains 1.5 mg of estradiol hemihydrate and 1.5 mg of levonorgestrel in a patch size of 15 cm2, releasing 50 micrograms of estradiol and 10 micrograms of levonorgestrel per 24 hours.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Transdermal patch

Octagonal, transparent, flexible, rounded-edge transdermal matrix patch located on an oversized removable protective liner.

4. Clinical Particulars

4.1 Therapeutic Indications

Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women.

Experience of treating women older than 65 years is limited.

4.2 Posology And Method Of Administration

For transdermal use.

Apply FemSeven Sequi once a week, i.e. replace each patch every 7 days. FemSeven Sequi is a continuous sequential hormone replacement therapy (HRT) without a treatment-off phase: as one patch is removed, the next is applied immediately.

Each treatment cycle with FemSeven Sequi consists of the successive application of two transdermal patches containing estradiol (phase 1) and then two transdermal patches containing estradiol and levonorgestrel (phase 2).

Accordingly, the following treatment cycle should b

1. Name Of The Medicinal Product

Minims Tropicamide 0.5 %.

2. Qualitative And Quantitative Composition

Clear, colourless, sterile eye drops containing tropicamide Ph. Eur. 0.5 % w/v.

3. Pharmaceutical Form

Single-use, sterile eye drops.

4. Clinical Particulars

4.1 Therapeutic Indications

As a topical mydriatic and cycloplegic.

4.2 Posology And Method Of Administration

Adults (including the elderly):

1 drop followed by a second drop after an interval of 5 minutes. A further 1 drop may be instilled after 30 minutes, if required.

Children:

At the discretion of the physician.

4.3 Contraindications

Do not use in patients with a known hypersensitivity to tropicamide.

Tropicamide is contraindicated in narrow angle glaucoma and in eyes where the filtration angle is narrow, as an acute attack of angle closure glaucoma may be precipitated.

4.4 Special Warnings And Precautions For Use

Use with caution in an inflamed eye, as hyperaemia greatly increases the rate of systemic absorption through the conjunctiva.

Care should be exercised in small children.

Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of drops via the naso-lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.)

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

None known.

4.6 Pregnancy And Lactation

FORTRAL INJECTION 30MG/ML

(Pentazocine, as lactate)

Read all of this leaflet carefully before you are given this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have further questions, please ask your doctor, nurse or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

In this leaflet:

  • 1. What Fortral is and what it is used for
  • 2. Before you are given Fortral
  • 3. How Fortral is given
  • 4. Possible side effects
  • 5. How Fortral is stored
  • 6. Further information

What Fortral Is And What It Is Used For

The name of your medicine is Fortral Injection 30mg/ml (called Fortral throughout this leaflet). Fortral contains a medicine called pentazocine (as lactate). Pentazocine belongs to a group of medicines called analgesics (painkillers).

Fortral is used to treat moderate to severe pain.

Before You Are Given Fortral

Do not have Fortral and tell your doctor if:

  • You are allergic (hypersensitive) to pentazocine or any of the other ingredients in your medicine (listed in Section 6: Further information). Signs of an allergic reaction include a rash and breathing problems. There can also b

1. Name Of The Medicinal Product

ZYDOL XL 150 mg tablets.

2. Qualitative And Quantitative Composition

Tablets containing tramadol hydrochloride 150 mg.

For excipients, see 6.1

3. Pharmaceutical Form

Prolonged release, white, film coated tablets, marked T 150.

4. Clinical Particulars

4.1 Therapeutic Indications

Treatment of moderate to severe pain.

4.2 Posology And Method Of Administration

ZYDOL XL tablets should be taken at 24-hourly intervals and must be swallowed whole and not chewed.

As with all analgesic drugs, the dose of tramadol should be adjusted according to the severity of the pain and the clinical response of the individual patient. The correct dosage for any individual patient is that which controls the pain with no or tolerable side effects for a full 24 hours. Patients transferring from immediate release tramadol preparations should have their total daily dose calculated, and start on the nearest dose in the ZYDOL XL range. It is recommended that patients are slowly titrated to higher doses to minimise transient side effects. The need for continued treatment should be assessed at regular intervals as withdrawal symptoms and dependence have been reported. (See Section 4.4 Special Warnings and Precautions for Use). A total daily dose of 400 mg should not be exceeded except in special clinical circumstances.

Adults and children over 12 years: The usual initial dose is one 150 mg tablet daily. If pain relief is not achieved, the dosage should be titrated upwards until pain relief is achieved.

Elderly and patients with renal or hepatic impairment: Dosing as for adults. The elimination half-life of tramadol may be prolonged in patients over 75 years. A starti

1. Name Of The Medicinal Product

SINGULAIR® Paediatric 5 mg Chewable Tablets

2. Qualitative And Quantitative Composition

One chewable tablet contains montelukast sodium, which is equivalent to 5 mg montelukast.

Excipient: Aspartame (E 951) 1.5 mg per tablet.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Chewable tablet.

Pink, round, biconvex, diameter 9.5 mm, with 'SINGULAIR' engraved on one side and 'MSD 275' on the other.

4. Clinical Particulars

4.1 Therapeutic Indications

SINGULAIR is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short-acting ?-agonists provide inadequate clinical control of asthma.

SINGULAIR may also be an alternative treatment option to low-dose inhaled corticosteroids for patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids (see section 4.2).

SINGULAIR is also indicated in the prophylaxis of asthma in which the predominant component is exercise-induced bronchoconstriction.

4.2 Posology And Method Of Administration

The dosage for paediatric patients 6-14 years of age is one 5 mg chewable tablet daily to be taken in the evening. If taken in connection with food, SINGULAIR should be taken 1 hour before or 2 hours after food. No dosage adjustment within this age group is necessary.

General recommendations:

The therapeutic effect of SINGULAIR on parameters of asth

1. Name Of The Medicinal Product

Lamisil® AT 1% Spray

2. Qualitative And Quantitative Composition

10mg terbinafine hydrochloride per 1g spray solution

For excipients, see Section 6.1.

3. Pharmaceutical Form

Cutaneous spray, solution

4. Clinical Particulars

4.1 Therapeutic Indications

The treatment of tinea pedis (athlete's foot) and tinea cruris, (dhobie (jock) itch) caused by Trichophyton (e.g. T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum) and Epidermophyton floccosum.

4.2 Posology And Method Of Administration

Adults

Lamisil AT 1% Spray is applied once daily, for one week. Cleanse and dry the affected areas thoroughly before applying Lamisil AT 1% Spray from a distance of 5 to 10 cm. A sufficient amount of spray solution should be applied to wet the treatment area(s) thoroughly, and to cover the affected skin and surrounding area.

Duration and frequency of treatment:

Interdigital type tinea pedis, and tinea cruris: Once a day for one week.

Relief of clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If there are no signs of improvement after two weeks, a physician should be consulted.

Use of Lamisil AT 1% Spray in the elderly

There is no evidence to suggest that elderly patients require different dosages or experience side effects different from those in younger patients.

Use of Lamisil AT 1% Spray in children

Not to be used in children under 16 years

1. Name Of The Medicinal Product

Roaccutane 10 mg soft capsules

2. Qualitative And Quantitative Composition

Each soft capsule contains 10 mg of isotretinoin.

Excipients: Contains soya bean oil (refined, hydrogenated and partially hydrogenated) and sorbitol (E420).

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Capsules, soft

10 mg capsules: Oval, opaque, brown-red capsules imprinted with ROA 10 in black ink.

4. Clinical Particulars

4.1 Therapeutic Indications

Severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic anti-bacterials and topical therapy.

4.2 Posology And Method Of Administration

Isotretinoin should only be prescribed by or under the supervision of physicians with expertise in the use of systemic retinoids for the treatment of severe acne and a full understanding of the risks of isotretinoin therapy and monitoring requirements.

The capsules should be taken with food once or twice daily.

Adults including adolescents and the elderly:

Isotretinoin therapy should be started at a dose of 0.5 mg/kg daily. The therapeutic response to isotretinoin and some of the adverse effects are dose-related and vary between patients. This necessitates individual dosage adjustment during therapy. For most patients, the dose ranges from 0.5-1.0 mg/kg per day.

Long-term remission and relapse rates are more closely related to the total dose administered than to either duration of treatment or daily dose. It has been shown that no substantial additional benefit is to be expected beyond a cum

Brexidol 20 mg Tablets

piroxicam betadex

Important things you need to know about Brexidol.

  • Brexidol is a non-steroidal anti-inflammatory medicine, prescribed to relieve the symptoms of arthritis.
  • You need to take it regularly to get the maximum benefit. Do not stop taking it without talking to your doctor.
  • Brexidol can cause side effects in some people (read Section 4 for details).
    If you have any signs of bleeding in the stomach or intestines or vomit blood, stop taking your tablets and contact your doctor immediatly.
  • Your doctor will regularly monitor your condition to check you are taking the correct dose of Brexidol.
  • Your doctor may prescribe other medicines for you to take at the same time as Brexidol to protect your stomach and intestines.
  • Taking other medicines, including other NSAIDs, may sometimes cause problems. Check with your doctor or pharmacist before taking any other medicines.

Now read the rest of this leaflet. It includes other important information on the safe use of this medicine that might be especially important for you.This leaflet was last updated on 12/2008.

In this leaflet:

  • 1. What Brexidol is and what it is used for
  • 2. Before you take Brexidol
  • 3. How to take Brexidol
  • 4. Possible side effects
  • 5. How

1. Name Of The Medicinal Product

Difflam Cream

or

Difflam-P Cream

2. Qualitative And Quantitative Composition

Each tube of Difflam Cream/ Difflam-P Cream contains Benzydamine Hydrochloride 3% w/w.

3. Pharmaceutical Form

Cream.

4. Clinical Particulars

4.1 Therapeutic Indications

Difflam Cream/ Difflam-P Cream is a topical analgesic and non-steroidal anti-inflammatory agent.

It is recommended as a short-term treatment for the relief of symptoms associated with painful inflammatory conditions of the musculo-skeletal system, including:

Acute inflammatory disorders such as myalgia and bursitis.

Traumatic conditions such as sprains, strains, contusions and the after-effects of fractures.

Difflam Cream/ Difflam-P Cream is well absorbed through the skin and has been shown to have anti-inflammatory and local anaesthetic actions.

4.2 Posology And Method Of Administration

Difflam Cream/ Difflam-P Cream should be massaged lightly into the affected area. Depending on the size of the site to be treated, 35 - 85 mm (1 - 2 g) should be applied three times daily and at the discretion of the doctor, up to six times daily in more severe conditions. It is recommended that treatment be limited to not more than ten days.

ELDERLY:

No special dosage recommendations are made for elderly patients.

4.3 Contraindications

Difflam Cream is contraindicated in patients with known hypersensitivity to any of the ingredients.

4.4 Special Warnings And Precautions For Use

To avoid possible irritation, Difflam Cream/ Difflam-P Cream

Boots Bite & Sting Relief 2 Years Plus Antihistamine Cream

(Mepyramine Maleate)

From 2 years

Relieves pain, itching and swelling

20 g e

Read all of this carton for full instructions.

What this medicine is for

A soothing antihistamine cream for the relief of pain, itching and swelling caused by insect bites and stings, and nettle stings.

Before you use this medicine

X Do not use:

  • If you are allergic to any of the ingredients or other antihistamines
  • If you have eczema or other skin conditions
  • If you are pregnant or breastfeeding, unless your doctor tells you to
  • On broken skin, sunburnt skin or on large areas of skin

Cetostearyl alcohol and lanolin may cause skin reactions (e.g. contact dermatitis).

How to use this medicine

Check the tube seal is not broken before first use. If it is, do not use the cream. Pierce tube seal with end of cap.

Apply to the skin only.

Adults and children of 2 years and over:

Smooth a very small amount on the affected area. Use the cream 2 or 3 times a day, for a maximum of 3 days.

Do not use on children under 2 years.

If a rash develops, or the condition gets worse, stop using the cream.

If symptoms do not go away talk to your doctor.

! If anyone accidentally swallows some:

Talk to a

Fleet Ready-to-Use 21.4g / 9.4g Enema

Sodium Dihydrogen Phosphate Dihydrate / Disodium Phosphate Dodecahydrate

Read all of this leaflet carefully because it contains important information for you.

This medicine is available without prescription. However, you need to use Fleet Ready-to-Use Enema carefully to get the best results from it.

  • Keep this leaflet. You may need to read it again.
  • Ask your pharmacist or doctor if you need more information or advice.
  • You must contact a doctor if your symptoms worsen or do not improve after 14 days.
  • If any side effect gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Information in this leaflet:

  • 1. What Fleet Ready-to-Use Enema is and what it is used for.
  • 2. Before you use Fleet Ready-to-Use Enema.
  • 3. How to use Fleet Ready-to-Use Enema.
  • 4. Possible side effects.
  • 5. How to store Fleet Ready-to-Use Enema.
  • 6. Further information.

What Fleet Ready-To-Use Enema Is And What It Is Used For

Fleet Ready-to-Use Enema is a bowel cleanser that acts by increasing the water content of your stools and in this way helps to relieve constipation and clear the bowel.

It can be used in the relief of occasional constipation and where bowel cleansing is required, such as prior to your endoscopy, bowel surgery or X-ray examination.

Before You Use Fleet Ready-To-Use Enema

Do not use Fleet Ready-to-Use Enema and tell your doctor if you:

  • Are al

1. Name Of The Medicinal Product

Apidra Solostar 100 Units/ml solution for injection in a pre-filled pen

2. Qualitative And Quantitative Composition

Each ml contains 100 Units insulin glulisine (equivalent to 3.49 mg).

Each pen contains 3 ml of solution for injection, equivalent to 300 Units.

Insulin glulisine is produced by recombinant DNA technology in Escherichia coli.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Solution for injection in a pre-filled pen.

Clear, colourless, aqueous solution.

4. Clinical Particulars

4.1 Therapeutic Indications

Treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.

4.2 Posology And Method Of Administration

The potency of this preparation is stated in units. These units are exclusive to Apidra and are not the same as IU or the units used to express the potency of other insulin analogues. (see section 5.1).

Apidra should be used in regimens that include an intermediate or long acting insulin or basal insulin analogue and can be used with oral hypoglycaemic agents.

The dose of Apidra should be individually adjusted.

Special populations

Renal impairment

The pharmacokinetic properties of insulin glulisine are generally maintained in patients with renal impairment. However, insulin requirements may be reduced in the presence of renal impairment (see section 5.2).

Hepatic impairment

The pharmacokinetic properties of insulin glulisine have not

1. Name Of The Medicinal Product

Nizoral 2% shampoo

2. Qualitative And Quantitative Composition

Ketoconazole 2% w/w.(each gram contains 20 mg)

For a full list of excipients, see 6.1

3. Pharmaceutical Form

Pink viscous shampoo.

4. Clinical Particulars

4.1 Therapeutic Indications

Prevention and treatment of infections in which the yeast Malassezia (previously called Pityrosporum) is likely to be involved, such as dandruff, seborrhoeic dermatitis and tinea (pityriasis) versicolor.

4.2 Posology And Method Of Administration

For topical administration.

Adults, Elderly and Children:

Wash affected areas and leave for 3-5 minutes before rinsing.

Treatment:

Dandruff and seborrhoeic dermatitis: Wash hair twice weekly for 2-4 weeks.
Tinea versicolor: Once daily for a maximum of 5 days.

Prophylaxis:

Dandruff and seborrhoeic dermatitis: Use once every 1-2 weeks.
Tinea versicolor: Once daily for a maximum of 3 days before exposure to sunshine.

1. Name Of The Medicinal Product

Phenergan Elixir.

2. Qualitative And Quantitative Composition

Promethazine hydrochloride 5 mg / 5 ml.

For excipients see section 6.1

3. Pharmaceutical Form

Elixir

4. Clinical Particulars

4.1 Therapeutic Indications

As symptomatic treatment for allergic conditions of the upper respiratory tract and skin including allergic rhinitis, urticaria and anaphylactic reactions to drugs and foreign proteins.

As an adjunct in preoperative sedation in surgery and obstetrics.

As an antiemetic.

For short term use:

Sedation and treatment of insomnia in adults.

As a paediatric sedative.

4.2 Posology And Method Of Administration

Route of administration: Oral.

Not for use in children under the age of 2 years (see section 4.3)

As an antihistamine in allergy:

Children 2-5 years

Either 5–15 mg as a single dose.

Or 5 mg bd.

Maximum daily dose 15 mg.

Children 5-10 years

Either 10–25 mg as a single dose.

Or 5-10 mg bd.

Maximum daily dose 25 mg.

1. Name Of The Medicinal Product

Prandin 0.5 mg, 1 mg and 2 mg tablets

2. Qualitative And Quantitative Composition

Each tablet contains 0.5 mg, 1 mg or 2 mg of repaglinide.

For a full list of excipients, see section 6.1.

3. Pharmaceutical Form

Tablet

Repaglinide tablets are white (0.5 mg), yellow (1 mg), peach-coloured (2 mg), round and convex and engraved with Novo Nordisk logo (Apis bull).

4. Clinical Particulars

4.1 Therapeutic Indications

Repaglinide is indicated in patients with type 2 diabetes (Non Insulin-Dependent Diabetes Mellitus (NIDDM)) whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in type 2 diabetes patients who are not satisfactorily controlled on metformin alone.

Treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

4.2 Posology And Method Of Administration

Repaglinide is given preprandially and is titrated individually to optimise glycaemic control. In addition to the usual self-monitoring by the patient of blood and/or urinary glucose, the patient's blood glucose must be monitored periodically by the physician to determine the minimum effective dose for the patient. Glycosylated haemoglobin levels are also of value in monitoring the patient's response to therapy. Periodic monitoring is necessary to detect inadequate lowering of blood glucose at the recommended maximum dose level (i.e. primary failure) and to detect loss of adequate blood glucose-lowering response after an initial period of effectiveness (i.e. secondary failure).

Short-term administration of repaglinide may be sufficient du

1. Name Of The Medicinal Product

Gynoxin 600 mg Vaginal Capsules

2. Qualitative And Quantitative Composition

Each vaginal capsule contains 600 mg of the active ingredient fenticonazole nitrate.

For excipients, see 6.1

3. Pharmaceutical Form

Vaginal capsule, soft

Ivory white, opaque, soft gelatin capsules

4. Clinical Particulars

4.1 Therapeutic Indications

Treatment of vulvovaginal candidiasis.

4.2 Posology And Method Of Administration

Route of Administration:

Intravaginal

Adults:

One 600 mg vaginal capsule once only, at bedtime.

The capsule must be introduced deeply into the vagina.

Gynoxin is not greasy, does not soil and can easily be removed with water.

Children:

The use of Gynoxin in children is not recommended.

4.3 Contraindications

Ascertained hypersensitive to the product and to other imidazole derivatives.

4.4 Special Warnings And Precautions For Use

The product should not be used in conjunction with barrier contraceptives.

In the event of a hypersensitivity reaction or development of resistant organisms, treatment should be discontinued and the physician consulted.

4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction

Not investigated. Since systemic absorption of fenticonazole after application is low, interactions with other drugs are unlikely.

4.6 Pregnancy And Lactation

Oral administration of fenticonazole in rats has been reported to produce prolonged gestation and embryotoxic effects after doses above

Zirtek

ALLERGY SOLUTION 1 mg/ml

cetirizine hydrochloride

once-a-day

What You Should Know About Your Medicine

Please read this leaflet carefully before you start taking this medicine. It provides a summary of the information currently available on Zirtek Allergy Solution. For further information or advice ask your doctor or pharmacist.

What Is In Zirtek Allergy Solution

Each pack contains 150 or 200 ml of a banana flavoured, sugar free oral solution; each ml containing 1 mg of cetirizine hydrochloride as the active ingredient. This medicine also contains sorbitol (E420), glycerol (E422), propylene glycol, saccharin sodium, methylhydroxybenzoate (E218), propylhydroxybenzoate (E216), banana flavouring, sodium acetate (E262), acetic acid (E260) and purified water.

Product licence number: PL 00039 / 0540

This medicine is manufactured and licenced by:

UCB Pharma Ltd
208 Bath Road
Slough
Berkshire
SL1 3WE

When Is Zirtek Allergy Solution Used

Your medicine belongs to the antihistamine group of drugs.

This medicine treats adults & children aged 2 years and over: suffering from hay fever (seasonal allergic rhinitis), y

1. Name Of The Medicinal Product

Panadol Extra Soluble Tablets

2. Qualitative And Quantitative Composition

Each tablet contains Paracetamol Ph.Eur. 500.0 mg and Caffeine Ph.Eur. 65.0 mg.

3. Pharmaceutical Form

Effervescent tablet.

4. Clinical Particulars

4.1 Therapeutic Indications

Panadol Extra is a mild analgesic and antipyretic formulated to give extra pain relief. The soluble tablets are recommended for the treatment of most painful and febrile conditions, for example, headache including migraine, backache, toothache, colds and influenza, sore throat, rheumatic pain and dysmenorrhoea.

4.2 Posology And Method Of Administration

Panadol Extra should be dissolved in at least half a tumblerful of water.

Adults:

Two tablets up to four times daily.

Do not exceed 8 tablets in 24 hours.

Elderly:

As for adults.

Children:

Not recommended for children under 12 years.

Method of Administration

Panadol Extra Soluble Tablets are for oral administration only.

4.3 Contraindications

Hypersensitivity to paracetamol, caffeine or any of the other constituents.

4.4 Special Warnings And Precautions For Use

Care is advised in the administration of paracetamol to patients with renal or hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease.

Excessive intake of caffeine (e.g. coffee, tea and some canned drinks) should be avoided while taking thi